An immediate hemolytic reaction induced by repeated administration of oxaliplatinCHEN, Vivien M. Y; THRIFT, Karen M; MOREL-KOPP, Marie-Christine et al.Transfusion (Philadelphia, PA). 2004, Vol 44, Num 6, pp 838-843, issn 0041-1132, 6 p.Article

Longitudinal assessment of oxaliplatin-induced neuropathyBURAKGAZI, A. Z; MESSERSMITH, W; VAIDYA, D et al.Neurology. 2011, Vol 77, Num 10, pp 980-986, issn 0028-3878, 7 p.Article

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathyPARK, Susanna B; LIN, Cindy S.-Y; KRISHNAN, Arun V et al.Brain. 2009, Vol 132, pp 2712-2723, issn 0006-8950, 12 p., 10Article

Oxaliplatin-induced immune pancytopeniaTALEGHANI, Behrouz Mansouri; FONTANA, Stefano; MEYER, Oliver et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 5, pp 704-708, issn 0041-1132, 5 p.Article

Efficacy of IT oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathyARGYRIOU, A. A; CHRONI, E; POLYCHRONOPOULOS, P et al.Neurology. 2006, Vol 67, Num 12, pp 2253-2255, issn 0028-3878, 3 p.Article

Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorptionARNDT, Patricia; GARRATTY, George; ISAAK, Edahn et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 4, pp 711-718, issn 0041-1132, 8 p.Article

Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposureLEE, Suh-Young; KANG, Hye-Ryun; SONG, Woo-Jung et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 1021-1029, issn 0344-5704, 9 p.Article

Implication des canaux ioniques dans l'hypersensibilité au froid induite par l'oxaliplatine = Oxaliplatin-induced cold hypersensitivity is due to remodeling of ion channels in nociceptorsDESCOEUR, Juliette; PEREIRA, Vanessa; LAZDUNSKI, Michel et al.Cancéro digest. 2011, Vol 3, Num 3, pp 215-217, issn 1953-5171, 3 p.Article

Amelioration of Oxaliplatin Neurotoxicity by Drugs in Humans and Experimental Animals: A MiniReview of Recent LiteratureALI, Badreldin H.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 4, pp 272-279, issn 1742-7835, 8 p.Article

Recognition and processing of cisplatin- and oxaliplatin-DNA adductsCHANEY, Stephen G; CAMPBELL, Sharon L; BASSETT, Ekaterina et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 1, pp 3-11, issn 1040-8428, 9 p.Conference Paper

5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patientsREERINK, O; MULDER, N. H; SZABO, B. G et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1969-1971, issn 0250-7005, 3 p.Article

Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin CWU, H. Irene; BROWN, James A; DORIE, Mary J et al.Cancer research (Baltimore). 2004, Vol 64, Num 11, pp 3940-3948, issn 0008-5472, 9 p.Article

Hydrolysis of oxaliplatin-evaluation of the acid dissociation constant for the oxalato monodentate complexJERREMALM, Elin; EKSBORG, Staffan; EHRSSON, Hans et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 2, pp 436-438, issn 0022-3549, 3 p.Article

Characterization of sequence-dependent synergy between ZD1839 ('Iressa') and oxaliplatinXU, Jian-Ming; AZZARITI, Amalia; SEVERINO, Montemuro et al.Biochemical pharmacology. 2003, Vol 66, Num 4, pp 551-563, issn 0006-2952, 13 p.Article

Reversible Posterior Leukoencephalopathy Syndrome Associated With OxaliplatinPINEDO, Daryl M; SHAH-KHAN, Farheen; SHAH, Prabodh C et al.Journal of clinical oncology. 2007, Vol 25, Num 33, pp 5320-5321, issn 0732-183X, 2 p.Article

Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donorsLEGER, Regina M; GARRATTY, George.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 8, pp 1740-1744, issn 0041-1132, 5 p.Article

Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocyclineBOYETTE-DAVIS, J; DOUGHERTY, P. M.Experimental neurology (Print). 2011, Vol 229, Num 2, pp 353-357, issn 0014-4886, 5 p.Article

The influence of the temperature of the dialysate on hyperglycemia during Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with OxaliplatinVANEESTER, J; WYFFELS, P. A. H; VAN LIMMEN, J. G. M et al.Acta anaesthesiologica belgica. 2011, Vol 62, Num 2, issn 0001-5164, p. 126Conference Paper

Immune-mediated pancytopenia induced by oxaliplatin: a case reportFONTAO-WENDEL, Rita; HOFF, Paulo M; LAZAR, Arlette et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 7, pp 1453-1459, issn 0041-1132, 7 p., 1Article

Organic cation transporters are determinants of oxaliplatin cytotoxicitySHUZHONG ZHANG; LOVEJOY, Katherine S; LIPPARD, Stephen J et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8847-8857, issn 0008-5472, 11 p.Article

Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor propertiesGHIRARDI, Orlando; LO GIUDICE, Pietro; ZANNA, Claudio et al.Anticancer research. 2005, Vol 25, Num 4, pp 2681-2687, issn 0250-7005, 7 p.Article

Oxaliplatin-induced immune mediated thrombocytopeniaBEG, Muhammad S; KOMROKJI, Rami S; AHMED, Kashif et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 925-927, issn 0344-5704, 3 p.Article

Oxaliplatin-related neurotoxicity : How and why?PASETTO, Lara Maria; D'ANDREA, Mario Rosario; ROSSI, Elena et al.Critical reviews in oncology/hematology. 2006, Vol 59, Num 2, pp 159-168, issn 1040-8428, 10 p.Article

Oxaliplatin and axonal Na⁺ channel function in vivoKRISHNAN, Arun V; GOLDSTEIN, David; FRIEDLANDER, Michael et al.Clinical cancer research. 2006, Vol 12, Num 15, pp 4481-4484, issn 1078-0432, 4 p.Article

Clinical pharmacokinetics of oxaliplatin : A critical reviewGRAHAM, M. A; LOCKWOOD, G. F; GREENSLADE, D et al.Clinical cancer research. 2000, Vol 6, Num 4, pp 1205-1218, issn 1078-0432Article